Patterns of psychotropic medication use in nursing homes: Surveys in Sydney, allowing comparisons over time and between countries

International Psychogeriatrics

Volumn 23, Issue 9, 2011, Pages 1520-1525

  Snowdon, John ^a   Galanos, Daniel ^a   Vaswani, Divya ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

acetylcholinesterase inhibitors; antidepressant; antipsychotic; anxiolytic; dosage; hypnotic; memantine; residential care

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CLONAZEPAM; DONEPEZIL; GALANTAMINE; HALOPERIDOL; HYPNOTIC AGENT; MEMANTINE; MIDAZOLAM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; RISPERIDONE; RIVASTIGMINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

AGE; AGED; ARTICLE; COGNITION; COMPARATIVE STUDY; DRUG USE; FEMALE; GENDER; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME; OUTCOME ASSESSMENT; PRESCRIPTION; RESIDENT;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; FEMALE; HOMES FOR THE AGED; HUMANS; HYPNOTICS AND SEDATIVES; MALE; NEW SOUTH WALES; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTROPIC DRUGS; SEX FACTORS; TIME FACTORS;

EID: 80052502393     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610211000445     Document Type: Article

References (20)

1. bains, J., birks, J. S. and Dening, T. R. (2002). Antidepressants for treating depression in dementia. Cochrane Database Systematic Review, 4, CD003944.
2. barca, M. L., Selbaek, G., Laks, J. and Engedal, K. (2009). Factors associated with depression in Norwegian nursing homes. International Journal of Geriatric Psychiatry, 24, 417-425.
3. bharucha, A. J., Dew, M. A., Miller, M. D., borson, S. and Reynolds, C. (2006). Psychotherapy in long-term care: a review. Journal of the American Medical Directors Association, 7, 568-580. (Pubitemid 44661083)
4. brodaty, H. et al. (2003). A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation and psychosis of dementia. Journal of Clinical Psychiatry, 64, 134-143.
5. Hosia-Randell, H. and Pitk, K. et al. (2005). Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs and Aging, 22, 793-800.
6. Hughes, C. M. et al. (2000). The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective. Journal of the American Geriatrics Society, 48, 931-937. (Pubitemid 30637302)
7. Kim, H. and Whall, A. L. (2006). Factors associated with psychotropic drug usage among nursing home residents with dementia. Nursing Research, 55, 252-258. (Pubitemid 44503656)
8. Lövheim, H., Sandman, P. O., Kallin, K., Karlsson, S. and Gustafson, Y. (2006). Relationship between antipsychotic drug use and behavioural and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care. International Psychogeriatrics, 18, 713-726. (Pubitemid 44623003)
9. Nijk, R. M., Zuidema, S.U. and Koopmans, R. T. C. M. (2009). Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia. International Psychogeriatrics, 21, 485-493.
10. Nishtala, P. S., McLachlan, A. J., bell, J. S. and Chen, T. F. (2010). Determinants of antipsychotic medication use among older people living in aged care homes in Australia. International Journal of Geriatric Psychiatry, 25, 449-457.
11. Patterson, S. M., Hughes, C. M., Crealey, G., Cardwell, C. and Lapane, K. L. (2010). An evaluation of an adapted US model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland study). Journal of the American Geriatrics Society, 58, 44-53.
12. Seitz, D. P., Gruneir, A., Conn, D. K. and Rochon, P. A. (2009). Cholinesterase inhibitor use in U.S. nursing homes: results from the national nursing home survey. Journal of the American Geriatrics Society, 57, 2269-2274.
13. Selbaek, G., Kirkevold, O. and Engedal, K. (2007). The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. International Journal of Geriatric Psychiatry, 22, 843-849. (Pubitemid 47455265)
14. Snowdon, J. (1999). A follow-up survey of psychotropic drug use in Sydney nursing homes. Medical Journal of Australia, 170, 299-301. (Pubitemid 29184736)
15. Snowdon, J., Vaughan, R., Miller, R., burgess, E. E. and Tremlett, P. (1995). Psychotropic drug use in Sydney nursing homes. Medical Journal of Australia, 163, 70-72.
16. Snowdon, J., Day, S. and baker, W. (2006). Current use of psychotropic medication in nursing homes. International Psychogeriatrics, 18, 241-250. (Pubitemid 43829874)
17. Stevenson, D. G. et al. (2010). Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. American Journal of Geriatric Psychiatry, 18, 1078-1092.
18. Tucker, M. and Hosford, I. (2008). Use of psychotropic medicines in residential care facilities for older people in Hawke's bay, New Zealand. New Zealand Medical Journal, 121, 18-25. (Pubitemid 351850316)
19. Westbury, J., Jackson, S., Gee, P. and Peterson, G. (2010). An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. International Psychogeriatrics, 22, 26-36.
20. Weyerer, S., Schäufele, M. and Hendlmeier, I. (2010). Evaluation of special and traditional dementia care in nursing homes: results from a cross-sectional study in Germany. International Journal of Geriatric Psychiatry, 25, 1159-1167.